PLATELET [H-3] PAROXETINE BINDING, 5-HT-STIMULATED CA2+ RESPONSE, AND 5-HT CONTENT IN WINTER SEASONAL AFFECTIVE-DISORDER

被引:32
|
作者
OZAKI, N [1 ]
ROSENTHAL, NE [1 ]
MAZZOLA, P [1 ]
CHIUEH, CC [1 ]
HARDIN, T [1 ]
GARCIABORREGUERO, D [1 ]
SCHWARTZ, PJ [1 ]
TURNER, E [1 ]
OREN, DA [1 ]
MURPHY, DL [1 ]
机构
[1] NIMH, CLIN SCI LAB, BETHESDA, MD 20892 USA
关键词
SEASONAL AFFECTIVE DISORDER; LIGHT THERAPY; SEROTONIN; PLATELET; CALCIUM; H-3] PAROXETINE BINDING;
D O I
10.1016/0006-3223(94)90641-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present study was designed to evaluate cellular serotonergic functions in winter seasonal affective disorder (SAD) using serotonin (5-HT)-stimulated Ca2+ response as an integrated measure of 5-HT2 receptor function in platelets, [H-3]paroxetine binding to characterize the platelet 5-HT transporter and 5-HT content as an index of the platelet storage capacity for this neurotransmitter amine. Purified density-dependent subpopulations of platelets in untreated and light-treated SAD patients and matched controls were investigated in order to control for possible variations in platelet turnover We found no differences between SAD patients and controls on any of the measures, nor between light therapy conditions in SAD patients, although We found a higher B-max of [H-3]paroxetine binding and 5-HT content in heavy platelets compared to light platelets. Although the validity of platelet serotonergic measures as a model for brain serotonergic systems still remains to be elucidated, we found no evidence of platelet serotonergic abnormalities in our sample of SAD patients.
引用
收藏
页码:458 / 466
页数:9
相关论文
共 50 条
  • [1] EFFECTS OF FLUOXETINE TREATMENT OF PLATELET H-3 IMIPRAMINE BINDING, 5-HT UPTAKE AND 5-HT CONTENT IN MAJOR DEPRESSIVE DISORDER
    WAGNER, A
    MONTERO, D
    MARTENSSON, B
    SIWERS, B
    ASBERG, M
    JOURNAL OF AFFECTIVE DISORDERS, 1990, 20 (02) : 101 - 113
  • [2] PLATELET [H-3] PAROXETINE BINDING TO 5-HT UPTAKE SITES IN ALZHEIMERS-DISEASE
    ANDERSSON, A
    ADOLFSSON, R
    ERIKSSON, K
    MARCUSSON, J
    NEUROBIOLOGY OF AGING, 1991, 12 (05) : 531 - 534
  • [4] AGE STABILITY OF HUMAN BRAIN 5-HT TERMINALS STUDIED WITH [H-3] PAROXETINE BINDING
    ANDERSSON, A
    SUNDMAN, I
    MARCUSSON, J
    GERONTOLOGY, 1992, 38 (03) : 127 - 132
  • [5] 5-HT RECEPTOR-BINDING IN POSTMORTEM BRAIN FROM PATIENTS WITH AFFECTIVE-DISORDER
    MCKEITH, IG
    MARSHALL, EF
    FERRIER, IN
    ARMSTRONG, MM
    KENNEDY, WN
    PERRY, RH
    PERRY, EK
    ECCLESTON, D
    JOURNAL OF AFFECTIVE DISORDERS, 1987, 13 (01) : 67 - 74
  • [6] PLATELET 5-HT UPTAKE SITES IN DEPRESSION - 3 CONCURRENT MEASURES USING [H-3] IMIPRAMINE AND [H-3] PAROXETINE
    LAWRENCE, KM
    FALKOWSKI, J
    JACOBSON, RR
    HORTON, RW
    PSYCHOPHARMACOLOGY, 1993, 110 (1-2) : 235 - 239
  • [7] THE INHIBITION OF PLATELET 5-HT RELEASE BY 5-HT1A AGONISTS AND THE BINDING OF [H-3] 8-OH-DPAT TO PLATELET MEMBRANES
    YOUDIM, MBH
    GAVISH, M
    MARMUR, S
    AVIRAM, M
    BIOGENIC AMINES, 1990, 7 (01) : 11 - 18
  • [8] AFFINITY MODULATION OF [H-3] IMIPRAMINE, [H-3] PAROXETINE AND [H-3] CITALOPRAM BINDING TO THE 5-HT TRANSPORTER FROM BRAIN AND PLATELETS
    PLENGE, P
    MELLERUP, ET
    LAURSEN, H
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1991, 206 (03): : 243 - 250
  • [9] Platelet 3H-imipramine, 3H-paroxetine and 5-HT2 binding sites in bipolar disorder
    Custal, N.
    Crespo, J. M.
    Morchon, S.
    Rosel, P.
    Soria, V.
    Hernandez, R.
    Cardoner, N.
    Urretavizcaya, M.
    Menchon, J. M.
    Vallejo, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S240 - S241
  • [10] INHIBITION OF K-STIMULATED H-3 ACH AND H-3 5-HT RELEASE BY BARBITURATES
    RICHTER, JA
    FEDERATION PROCEEDINGS, 1979, 38 (03) : 274 - 274